the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

343 new dengue cases reported in ME19 – MOH

PUTRAJAYA: A total of 343 new cases of dengue fever were reported in the 19th Epidemiological Week (ME19) from May 5-11, taking the total number of cases to 2,338 compared to 1,995 the previous week.

Health director-general Datuk Dr Muhammad Radzi Abu Hassan said one death due to dengue fever complications was recorded during that period.

He said the cumulative number of reported dengue fever cases until ME19 is 57,220 compared to 41,175 cases for the same period in 2023, adding that there were 40 fatalities due to dengue fever complications (ME19) compared to 26 deaths for the same period in 2023.

“There were 60 hotspots reported in ME19 compared to 70 the previous week.

“Of the 60 hotspots reported, 45 were in Selangor; Kuala Lumpur and Putrajaya (seven); Sarawak (three); Penang (two); and one each in Kedah, Perak and Negeri Sembilan,” he said in a statement today.

As for the expected decrease in rainfall and warmer weather during the Southwest Monsoon, he said the situation could contribute to an increase in the population of Aedes mosquitoes.

As such, the public is advised to continue ensuring there are no Aedes mosquito breeding places inside and outside houses by “seeking and destroying” such breeding places at least 10 minutes once a week.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings